Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal

The innate immune system senses the invasion of pathogenic microorganisms and tissue injury through Toll-like receptors (TLR), a mechanism thought to be limited to immune cells. We recently found that neurons express several TLRs, and that the levels of TLR2 and TLR4 are increased in neurons in resp...

Full description

Saved in:
Bibliographic Details
Published inExperimental neurology Vol. 213; no. 1; pp. 114 - 121
Main Authors Tang, Sung-Chun, Lathia, Justin D., Selvaraj, Pradeep K., Jo, Dong-Gyu, Mughal, Mohamed R., Cheng, Aiwu, Siler, Dominic A., Markesbery, William R., Arumugam, Thiruma V., Mattson, Mark P.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.09.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The innate immune system senses the invasion of pathogenic microorganisms and tissue injury through Toll-like receptors (TLR), a mechanism thought to be limited to immune cells. We recently found that neurons express several TLRs, and that the levels of TLR2 and TLR4 are increased in neurons in response to energy deprivation. Here we report that TLR4 expression increases in neurons when exposed to amyloid β-peptide (Aβ1–42) or the lipid peroxidation product 4-hydroxynonenal (HNE). Neuronal apoptosis triggered by Aβ and HNE was mediated by jun N-terminal kinase (JNK); neurons from TLR4 mutant mice exhibited reduced JNK and caspase-3 activation and were protected against apoptosis induced by Aβ and HNE. Levels of TLR4 were decreased in inferior parietal cortex tissue specimens from end-stage AD patients compared to aged-matched control subjects, possibly as the result of loss of neurons expressing TLR4. Our findings suggest that TLR4 signaling increases the vulnerability of neurons to Aβ and oxidative stress in AD, and identify TLR4 as a potential therapeutic target for AD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-4886
1090-2430
1090-2430
DOI:10.1016/j.expneurol.2008.05.014